🇺🇸 FDA
Patent

US 7815908

Methods and compositions for treating and preventing disease associated with αVβ5 integrin

granted A61KA61K2039/505A61P

Quick answer

US patent 7815908 (Methods and compositions for treating and preventing disease associated with αVβ5 integrin) held by The Regents of the University of California expires Mon Oct 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Oct 19 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K2039/505, A61P, A61P11/00, A61P35/00